Our columnist suggests how to think about stocks and bonds during a presidency that is signaling a deep devotion to profits.

Moderna (MRNA) stock gained in the premarket after the company received a tender to supply its COVID-19 vaccine in the EU, ...

We recently published a list of These 10 Firms Were Thursday’s Top Performers. In this article, we are going to take a look ...

Moderna stock has fallen over the past four years, but shares got a boost on positive comments about AI. Is MRNA stock a buy ...

H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva (VALN – Research Report) today and set a price target of $18.00.Invest ...

SINGAPORE: The updated JN.1 Novavax/Nuvaxovid COVID-19 vaccine will be offered under the national vaccination programme at ...

Barron's reporters have screened for potentially attractive stocks based on a variety of metrics. Here are the stocks they have identified for investors to research further. Barron's reporters ...

Adar Poonawalla, CEO, Serum Institute of India talks to Arijit Barman about a range of issues including the impact of Trump’s ...

President Donald Trump's boost to AI demand hopes is outweighing fresh tariff threats on China and the EU, as earnings season ...

Space stocks — Intuitive Machines (LUNR), Rocket Lab (RKLB), AST SpaceMobile (ASTS), Virgin Galactic (SPCE), Globalstar (GSAT) — rallied Tuesday afternoon following President Trump's ...

President Donald Trump talked up a joint venture investing up to $500 billion for infrastructure tied to AI by a new ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...